Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
35
days
Prognostic significance of walking ability at hospital discharge for overall survival in newly diagnosed glioblastoma: a comparison across six peri-treatment assessments
Authors
Shuhei Tokiwa; Keisuke Natsume; Akira Yoshida; Hajime Yonezawa; Kentaro Kawamura; Kazuki Nakanishi; Nayuta Higa; Ryosuke Hanaya; Megumi ShimodozonoShow moreShow less
Affiliations
1. Department of Rehabilitation, Kagoshima University Hospital, Kagoshima, Japan; 2. Department of Rehabilitation and Physical Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan; 3. Department of Neurosurgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan; 4. Department of Physical Therapy, School of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, JapanShow moreShow less
78
days
Assessing the personal financial impact of vestibular schwannoma management
Authors
Robert J. Macielak; William Liu; Nicholas S. Andresen; Yin Ren; Edward E. Dodson; Daniel M. Prevedello; Oliver F. Adunka; Kyle C. Wu; Desi P. SchooShow moreShow less
Affiliations
1. Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, USA; 2. The Ohio State University College of Medicine, Columbus, USA; 3. Department of Neurosurgery, The Ohio State University Wexner Medical Center, Columbus, USAShow moreShow less
18
days
Contrast enhancement: the missing imaging variable in IDH-wildtype gliomas with historical WHO grade 2 and 3 histology
Authors
Alexandre Roux; Marc Zanello; Johan PalludShow moreShow less
Affiliations
1. Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences - Hôpital Sainte Anne, Paris, FranceShow moreShow less
55
days
Diffusion histogram analysis predicts progression-free survival in contrast enhancing recurrent IDH mutant gliomas treated with bevacizumab
Authors
Elizabeth Loxterkamp; Audrey Luo; Francesco Sanvito; Collin T. Le; Catalina Raymond; Chuyin Yang; Terry J. Prins; Addison Fisher; Noriko Salamon; Linda M. Liau; Robert A. Chong; Phioanh L. Nghiemphu; David A. Nathanson; Timothy F. Cloughesy; Albert Lai; Benjamin M. EllingsonShow moreShow less
Affiliations
1. UCLA Brain Tumor Imaging Laboratory (BTIL), Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA; 2. Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA; 3. Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA; 4. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA; 5. Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, Los Angeles, USA; 6. Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USAShow moreShow less
126
days
Stereotactic radiosurgery for brain metastases from male breast cancer: a multicenter retrospective study
Authors
Ali H. Duzkalir; Mehmet O. Askeroglu; Dogu C. Yildirim; Kristen Marciniuk; Kenneth Bernstein; Salem M. Tos; Jheremy S. Reyes; Roman Liscak; Gabriela Simonova; Takuma Sumi; Hideyuki Kano; Turker Kilic; Deniz Kilic; Greg N. Bowden; Shachar Z. Shemesh; Tehila Kaisman-Elbaz; Cheng-chia Lee; Huai-che Yang; Tugce Kutuk; Joshua D. Palmer; David Mathieu; Constantinos G. Hadjipanayis; Ajay Niranjan; Jason P. Sheehan; Douglas Kondziolka; L. Dade Lunsford; Selcuk PekerShow moreShow less
Affiliations
1. Department of Neurosurgery, Koc University Hospital, Istanbul, Türkiye; 2. Gamma Knife Center, Koc University Hospital, Istanbul, Türkiye; 3. Department of Neurosurgery, NYU Langone Medical Center, New York, USA; 4. Department of Radiation Oncology, NYU Langone Medical Center, New York, USA; 5. Department of Neurological Surgery, University of Virginia, Charlottesville, USA; 6. Center for Image-Guided Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, USA; 7. Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague, Czech Republic; 8. Department of Neurosurgery, Dokkyo Medical University, Mibu, Japan; 9. Department of Neurosurgery, Istinye University, Istanbul, Türkiye; 10. Department of Neurosurgery, Bahcesehir University, Istanbul, Türkiye; 11. Department of Neurosurgery, University of Alberta, Edmonton, Canada; 12. Department of Neurosurgery, Sheba Tel-Hashomer Medical Center, Ramat Gan, Israel; 13. Department of Neurosurgery, Neurological Institute, Taipei Veteran General Hospital, Taipei, Taiwan; 14. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; 15. Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, USA; 16. Centre de recherche du CHUS, Department of Neurosurgery, Université de Sherbrooke, Québec, Canada; 17. Department of Neurosurgery, School of Medicine, Koc University Hospital, Istanbul, TürkiyeShow moreShow less
18
days
Treatment selection or treatment effect? Interpreting functional outcomes in motor cortex metastases
Authors
Volkan DemircanShow moreShow less
Affiliations
1. Department of Radiation Oncology, Bahçeşehir University Faculty of Medicine, Istanbul, TürkiyeShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
